{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:43:52Z","timestamp":1792215832338,"version":"4.4.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82201867"],"award-info":[{"award-number":["82201867"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.fct.2026.116412","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:48:16Z","timestamp":1791503296000},"page":"116412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An MMP12-enriched Kupffer cell-associated programme links ATF3-associated immunometabolic remodeling to hepatic metabolic dysfunction and fibrotic communication networks"],"prefix":"10.1016","volume":"219","author":[{"given":"Jing","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-Pan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1849-6523","authenticated-orcid":false,"given":"Tian-Rong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fct.2026.116412_bib1","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/LVT.0000000000000245","article-title":"Overcoming the hurdles of steatotic grafts in liver transplantation: insights into survival and prognostic factors","volume":"30","author":"Akabane","year":"2024","journal-title":"Liver Transplant."},{"key":"10.1016\/j.fct.2026.116412_bib2","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1039\/D5LC00221D","article-title":"LEADS - a comprehensive human liver-on-a-chip for non-alcoholic steatohepatitis (NASH) drug testing","volume":"25","author":"Balachander","year":"2025","journal-title":"Lab Chip"},{"key":"10.1016\/j.fct.2026.116412_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2026.1765215","article-title":"Vitamin D and the metabolic-associated steatotic liver disease-type 2 diabetes axis: a scoping-narrative review of global evidence and emerging perspectives for Sub-Saharan Africa","volume":"6","author":"Basil","year":"2026","journal-title":"Front Epidemiol"},{"key":"10.1016\/j.fct.2026.116412_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/nu18101595","article-title":"Hot topics in nutrition and obesity: integrating epidemiology, mechanisms, and therapeutic perspectives","volume":"18","author":"Catalan","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.fct.2026.116412_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2026.116962","article-title":"Endogenous phosphatidylcholine 16:0\/20:4 increases to promote liver regeneration in hepatectomy","volume":"29","author":"Cen","year":"2026","journal-title":"iScience"},{"key":"10.1016\/j.fct.2026.116412_bib6","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.26.34836","article-title":"Screening for fibrosis in metabolic dysfunction-associated steatotic liver disease: evidence, challenges, and the role of imaging-from the AJR special series on screening","author":"Chan","year":"2026","journal-title":"AJR Am. J. Roentgenol."},{"key":"10.1016\/j.fct.2026.116412_bib7","doi-asserted-by":"crossref","first-page":"298","DOI":"10.7570\/jomes26005","article-title":"Pharmacological therapy for metabolic dysfunction-associated steatotic liver disease in a new era for obesity and metabolic medicine: a state-of-the-art review","volume":"35","author":"Chan","year":"2026","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/j.fct.2026.116412_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11684-025-1133-7","article-title":"Aging and metabolic dysfunction-associated steatotic liver disease: a bidirectional relationship","volume":"19","author":"Chen","year":"2025","journal-title":"Front. Med."},{"key":"10.1016\/j.fct.2026.116412_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/antiox13060729","article-title":"Liver cell mitophagy in Metabolic dysfunction-associated steatotic liver disease and liver fibrosis","volume":"13","author":"Chen","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.fct.2026.116412_bib10","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1007\/s12015-026-11186-6","article-title":"Targeted strategies of adipose stem cells for metabolic diseases: mechanisms and clinical translation challenges","volume":"22","author":"Chen","year":"2026","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.fct.2026.116412_bib11","doi-asserted-by":"crossref","DOI":"10.2147\/DMSO.S604828","article-title":"Telomere length in metabolic syndrome: mechanisms, epidemiology and clinical implications: a narrative review","volume":"19","author":"Cilia","year":"2026","journal-title":"Diabetes Metab. Syndr. Obes."},{"key":"10.1016\/j.fct.2026.116412_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/eji.70217","article-title":"Managing autofluorescence in spectral flow cytometry for macrophage identification in the liver","volume":"56","author":"Daemen","year":"2026","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.fct.2026.116412_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.dld.2025.01.189","article-title":"Liver sinusoidal endothelial cells: friend or foe in metabolic dysfunction- associated steatotic liver disease\/metabolic dysfunction-associated steatohepatitis","volume":"57","author":"Dai","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.fct.2026.116412_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2026.100479","article-title":"What's in a name? From PCOS to polyendocrine metabolic ovarian syndrome: a metabolic reframing, promise, controversies, and challenges ahead","volume":"30","author":"Dalamaga","year":"2026","journal-title":"Metabol Open"},{"key":"10.1016\/j.fct.2026.116412_bib15","article-title":"Periodontitis and metabolic dysfunction-associated steatotic liver disease","volume":"2000","author":"de Molon","year":"2026","journal-title":"Periodontol"},{"key":"10.1016\/j.fct.2026.116412_bib16","doi-asserted-by":"crossref","DOI":"10.2147\/IJGM.S611499","article-title":"Multi-target intervention of traditional Chinese medicine in metabolic dysfunction-associated steatohepatitis: comprehensive treatment strategies from lipotoxicity to immune regulation","volume":"19","author":"Deng","year":"2026","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.fct.2026.116412_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101175","article-title":"The burden of liver disease in Latin America","volume":"29","author":"Diaz","year":"2024","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.fct.2026.116412_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/dj13110503","article-title":"Liver disease and periodontal pathogens: a bidirectional relationship between liver and oral microbiota","volume":"13","author":"Dioguardi","year":"2025","journal-title":"Dent. J."},{"key":"10.1016\/j.fct.2026.116412_bib19","article-title":"Single-cell fixed RNA profiling uncovers SEMA4D and LMCD1 as therapeutic targets in a liver fibrosis model","volume":"8","author":"Duc","year":"2026","journal-title":"JHEP Rep."},{"key":"10.1016\/j.fct.2026.116412_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/jpp\/rgag055","article-title":"Ferulic acid ameliorates metabolic dysfunction associated with fatty liver disease by regulating macrophage polarization through spermidine derived from gut microbiota","volume":"78","author":"Feng","year":"2026","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.fct.2026.116412_bib21","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jhep.2024.05.014","article-title":"Angiocrine signaling in sinusoidal homeostasis and liver diseases","volume":"81","author":"Gao","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.fct.2026.116412_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1835489","article-title":"Targeting macrophages in liver fibrosis","volume":"17","author":"Gonzalez Del Barrio","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2026.116412_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ajpath.2025.05.013","article-title":"Identification of preclinical biomarkers of Metabolic dysfunction-associated steatotic liver disease versus metabolic dysfunction and alcohol-associated liver disease and the impact of diet","volume":"196","author":"Gripshover","year":"2026","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.fct.2026.116412_bib24","doi-asserted-by":"crossref","first-page":"4286","DOI":"10.1038\/s41467-025-58790-7","article-title":"Hepatic AKAP1 deficiency exacerbates diet-induced MASLD by enhancing GPAT1-mediated lysophosphatidic acid synthesis","volume":"16","author":"He","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.fct.2026.116412_bib25","article-title":"Complement 3a receptor 1 on macrophages and kupffer cells is not required for the pathogenesis of metabolic dysfunction-associated steatotic liver disease","author":"Homan","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/j.fct.2026.116412_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2023.101278","article-title":"A data-driven approach to decode metabolic dysfunction-associated steatotic liver disease","volume":"29","author":"Jimenez Ramos","year":"2024","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.fct.2026.116412_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/biom16050651","article-title":"Naringin attenuates steatosis, oxidative stress, inflammation, and Fibrosis in MASH: network pharmacology and in vivo study","volume":"16","author":"Kim","year":"2026","journal-title":"Biomolecules"},{"key":"10.1016\/j.fct.2026.116412_bib28","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.cld.2026.01.010","article-title":"Metabolic dysfunction-associated steatotic liver disease in Asia: epidemiology, clinical features, and management","volume":"30","author":"Kobayashi","year":"2026","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.fct.2026.116412_bib29","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.3748\/wjg.v30.i28.3428","article-title":"Effects of elafibranor on liver fibrosis and gut barrier function in a mouse model of alcohol-associated liver disease","volume":"30","author":"Koizumi","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.fct.2026.116412_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-026-04499-5","article-title":"Revisiting cannabinoid receptor-2: a key regulator of hepatic steatosis, inflammatory cascades, and fibrotic progression","author":"Kumari","year":"2026","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.fct.2026.116412_bib31","doi-asserted-by":"crossref","first-page":"93","DOI":"10.21037\/tgh-2026-0031","article-title":"Liver reprogramming toward hepatocellular carcinoma following hepatitis C sustained virologic response: a narrative review","volume":"11","author":"Le","year":"2026","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.fct.2026.116412_bib32","article-title":"Loss of immunometabolic adaptability in MASH: gut-derived signals drive macrophage reprogramming and fibrosis","volume":"17","author":"Li","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2026.116412_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70576","article-title":"Targeting the LPI\/GPR55 axis in MAFLD and MASH: novel insights, therapeutic strategies and future directions","volume":"46","author":"Lian","year":"2026","journal-title":"Liver Int."},{"key":"10.1016\/j.fct.2026.116412_bib34","article-title":"Dissecting acute drug-induced hepatotoxicity and therapeutic responses of steatotic liver disease using primary mouse liver and blood cells in a Liver-On-A-Chip model","volume":"11","author":"Liu","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.fct.2026.116412_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/978-1-0716-3437-0_15","article-title":"Studying macrophages in the Murine steatotic liver using flow cytometry and confocal microscopy","volume":"2713","author":"Liu","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.fct.2026.116412_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000975","article-title":"Gut microbiota-derived indole-3-propionic acid alleviates endoplasmic reticulum stress by regulating FMO2 in MASLD","volume":"10","author":"Luo","year":"2026","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.fct.2026.116412_bib37","first-page":"803","article-title":"Bidirectional relationship between metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus","volume":"25","author":"Mantovani","year":"2026","journal-title":"EXCLI J."},{"key":"10.1016\/j.fct.2026.116412_bib38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1053\/j.jvca.2023.11.039","article-title":"Perioperative cardiovascular risk assessment and management in liver transplant recipients: a review of the literature Merging Guidelines and interventions","volume":"38","author":"Martinez-Perez","year":"2024","journal-title":"J. Cardiothorac. Vasc. Anesth."},{"key":"10.1016\/j.fct.2026.116412_bib39","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202504360R","article-title":"Single cell analysis reveals the presence of novel intermediate cells in both mice and patients with severe MASLD","volume":"40","author":"Meroni","year":"2026","journal-title":"FASEB J."},{"key":"10.1016\/j.fct.2026.116412_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics16162502","article-title":"Multiparametric ultrasound in chronic viral hepatitis: from fibrosis and portal hypertension to steatosis and focal lesion characterisation","volume":"16","author":"Mirowski","year":"2026","journal-title":"Diagnostics"},{"key":"10.1016\/j.fct.2026.116412_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2600215123","article-title":"CXCR4-targeted dual softener for inducing senescence therapy in hepatic fibrosis","volume":"123","author":"Mu","year":"2026","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.fct.2026.116412_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0001500","article-title":"A conceptual agentic AI architecture for MASLD-associated significant fibrosis in primary care","volume":"5","author":"Njei","year":"2026","journal-title":"PLOS Digit. Health"},{"key":"10.1016\/j.fct.2026.116412_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.dld.2026.08.009","article-title":"Steatosis liver index: a validated machine learning model using clinical data distinguishes steatotic liver disease phenotypes","author":"Pagadala","year":"2026","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.fct.2026.116412_bib44","doi-asserted-by":"crossref","DOI":"10.3390\/cells15050464","article-title":"Peroxisome proliferator-activated receptor beta\/delta: a link between metabolism, inflammation, and fibrosis in Metabolic dysfunction-associated steatotic liver disease","volume":"15","author":"Palomer","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.fct.2026.116412_bib45","doi-asserted-by":"crossref","first-page":"G60","DOI":"10.1152\/ajpgi.00462.2025","article-title":"Macrophage-specific autotaxin deficiency promotes hepatic steatosis and inflammation in diet-induced MASLD","volume":"331","author":"Park","year":"2026","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.fct.2026.116412_bib46","article-title":"Clinical presentation of a patient with hemochromatosis after bariatric surgery with HFE (H63D) mutation","volume":"14","author":"Petridis","year":"2026","journal-title":"J. Invest. Med. High Impact Case Rep."},{"key":"10.1016\/j.fct.2026.116412_bib47","first-page":"290","article-title":"The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease","volume":"19","author":"Platek","year":"2024","journal-title":"Przegl\u0105d Gastroenterol."},{"key":"10.1016\/j.fct.2026.116412_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1290391","article-title":"Role of the co-stimulatory molecule inducible T-cell co-stimulator ligand (ICOSL) in the progression of experimental metabolic dysfunction-associated steatohepatitis","volume":"14","author":"Provera","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2026.116412_bib49","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-026-06816-0","article-title":"Screening and diagnosis of liver disease in diabetes: a guide and evidence-based assessment","author":"Qadri","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/j.fct.2026.116412_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2026.103608","article-title":"Digital pathology-enabled artificial intelligence for fibrosis assessment in Metabolic dysfunction-associated steatohepatitis: needs, Current progress, and barriers","volume":"16","author":"Rastogi","year":"2026","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.fct.2026.116412_bib51","doi-asserted-by":"crossref","DOI":"10.1186\/s43556-026-00486-5","article-title":"Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options","volume":"7","author":"Ren","year":"2026","journal-title":"Mol Biomed"},{"key":"10.1016\/j.fct.2026.116412_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1407555","article-title":"Bariatric-induced microbiome changes alter MASLD development in association with changes in the innate immune system","volume":"15","author":"Shera","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.fct.2026.116412_bib53","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/SHK.0000000000002610","article-title":"IQGAP-1 mediated activation of the kupffer cells contributes to the progression of Metabolic dysfunction-associated steatotic liver disease","volume":"64","author":"Sun","year":"2025","journal-title":"Shock"},{"key":"10.1016\/j.fct.2026.116412_bib54","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ultrasmedbio.2025.09.022","article-title":"The bubble-destruction curve obtained using contrast-enhanced ultrasound is useful for assessing liver fibrosis and identifying At-risk MASH in patients with MASLD","volume":"52","author":"Wakui","year":"2026","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.fct.2026.116412_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114554","article-title":"GPNMB regulates the differentiation and transformation of monocyte-derived macrophages during MASLD","volume":"154","author":"Wang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.fct.2026.116412_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2024.167020","article-title":"Extracellular vesicles derived from liver sinusoidal endothelial cells inhibit the activation of hepatic stellate cells and Kupffer cells in vitro","volume":"1870","author":"Wang","year":"2024","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.fct.2026.116412_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/cen.14990","article-title":"Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: a cross-sectional and prospective study of 368,634 UK Biobank participants","volume":"100","author":"Wang","year":"2024","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.fct.2026.116412_bib58","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-026-10624-y","article-title":"Polypharmacy among older adults with metabolic dysfunction-associated steatotic liver disease","author":"Wang","year":"2026","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.fct.2026.116412_bib59","article-title":"Natural polysaccharides as immunometabolic modulators in metabolic diseases: mechanisms and translational challenges","volume":"17","author":"Wang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2026.116412_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70268","article-title":"Liver organoids: from disease modelling to regenerative medicine","author":"Wang","year":"2026","journal-title":"Cell Prolif."},{"key":"10.1016\/j.fct.2026.116412_bib61","article-title":"Global Co-Occurrence patterns of ischemic heart disease and metabolic dysfunction-associated steatotic liver disease: spatial clusters, risk factors, and quality-of-care index","volume":"15","author":"Wang","year":"2026","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.fct.2026.116412_bib62","article-title":"A PNPLA3-NACC1-RIPK3 pathway mediates macrophage necroptosis and inflammation in MASLD","volume":"10","author":"Wang","year":"2026","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.fct.2026.116412_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/s12893-026-03747-w","article-title":"Construction and metabolic efficacy evaluation of sleeve gastrectomy and modified Roux-en-Y gastric bypass in a mouse model with obesity and MASLD","volume":"26","author":"Wang","year":"2026","journal-title":"BMC Surg."},{"key":"10.1016\/j.fct.2026.116412_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1924392","article-title":"The NLRP3 inflammasome in metabolic dysfunction-associated steatotic liver disease: role and advances in therapeutic targeting","volume":"17","author":"Wei","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.fct.2026.116412_bib65","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.cytogfr.2026.07.003","article-title":"The role of cellular senescence in metabolic dysfunction-associated steatotic liver disease","volume":"91","author":"Wen","year":"2026","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.fct.2026.116412_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.179106","article-title":"Valerenic acid attenuates chronic stress-exacerbated metabolic dysfunction-associated steatotic liver disease via the estrogen receptor alpha-GDF15 axis","volume":"1030","author":"Wu","year":"2026","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.fct.2026.116412_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2025.123879","article-title":"Liver sinusoidal endothelial cells: central mediators of MASLD pathogenesis and sepsis susceptibility","volume":"379","author":"Wu","year":"2025","journal-title":"Life Sci."},{"key":"10.1016\/j.fct.2026.116412_bib68","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00109-025-02612-2","article-title":"cGAS-STING signaling pathway in MASLD and liver fibrosis","volume":"104","author":"Xiao","year":"2026","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.fct.2026.116412_bib69","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1007\/s12072-026-11096-2","article-title":"Clinical trial endpoints for metabolic dysfunction and alcohol associated steatotic liver disease","volume":"20","author":"Xie","year":"2026","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.fct.2026.116412_bib70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5582\/bst.2024.01097","article-title":"Suppression of STK39 weakens the MASLD\/MASH process by protecting the intestinal barrier","volume":"18","author":"Xu","year":"2024","journal-title":"Biosci Trends"},{"key":"10.1016\/j.fct.2026.116412_bib71","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1650677","article-title":"Immunosenescence and metabolic reprogramming in MASLD: an age-dependent immunometabolic vicious cycle and therapeutic opportunities","volume":"13","author":"Xu","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.fct.2026.116412_bib72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/10799907261432064","article-title":"Serum level of Interleukin-11 is associated with the severity of hepatic fibrosis in adults with metabolic dysfunction-associated steatotic liver disease","volume":"46","author":"Xue","year":"2026","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.fct.2026.116412_bib73","article-title":"Macrophage and inflammation in diabetes and metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutic strategies","volume":"16","author":"Zhang","year":"2025","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.fct.2026.116412_bib74","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s12072-025-10792-9","article-title":"A robust diagnostic model for high-risk MASH: integrating clinical parameters and circulating biomarkers through a multi-omics approach","volume":"19","author":"Zhang","year":"2025","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.fct.2026.116412_bib75","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1016\/j.cmet.2024.05.008","article-title":"Reactive oxygen species regulation by NCF1 governs ferroptosis susceptibility of Kupffer cells to MASH","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.fct.2026.116412_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1680878","article-title":"Macrophage-tregs crosstalk: the \"hub\" of the immune network in MASLD","volume":"16","author":"Zhao","year":"2025","journal-title":"Front. Immunol."}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526004874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691526004874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:18:47Z","timestamp":1792214327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691526004874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":76,"alternative-id":["S0278691526004874"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2026.116412","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An MMP12-enriched Kupffer cell-associated programme links ATF3-associated immunometabolic remodeling to hepatic metabolic dysfunction and fibrotic communication networks","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2026.116412","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116412"}}